Schering-Plough
SGP
#544
Rank
A$65.62 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : A$11.61 Billion

According to Schering-Plough's latest financial reports the company's total debt is A$11.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31A$11.58 B
2006-12-31A$3.36 B-32.95%
2005-12-31A$5.02 B-1.82%
2004-12-31A$5.11 B10.83%
2003-12-31A$4.61 B-39.67%
2002-12-31A$7.65 B105.63%
2001-12-31A$3.72 B-20.85%
2000-12-31A$4.70 B
1998-12-31A$3.35 B-11.06%
1997-12-31A$3.76 B169.42%
1996-12-31A$1.39 B